Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort

Author:

Ma Jimmy1ORCID,Nance Robin M1,Delaney Joseph A C2,Whitney Bridget M1,Bamford Laura3,Gravett Ronnie M4,Moore Richard D5,Napravnik Sonia6,Mayer Kenneth H7,Jacobson Jeffrey M8,Christopoulos Katerina9,Burkholder Greer A4,Keruly Jeanne5,Eron Joseph J6,Martin Jeffrey10,Cachay Edward R3,Saag Michael S4,Crane Heidi M1,Kitahata Mari M1

Affiliation:

1. Department of Medicine, University of Washington , Seattle, Washington , USA

2. College of Pharmacy, University of Manitoba , Winnipeg, Manitoba , Canada

3. Department of Medicine, University of California , San Diego, California , USA

4. Department of Medicine, University of Alabama , Birmingham, Alabama , USA

5. Department of Medicine, Johns Hopkins University , Baltimore, Maryland , USA

6. Department of Medicine, University of North Carolina , Chapel Hill, North Carolina , USA

7. Fenway Health Institute and Harvard Medical School , Boston, Massachusetts , USA

8. Department of Medicine, Case Western Reserve University , Cleveland, Ohio , USA

9. Department of Medicine, University of California , San Francisco, California , USA

10. Department of Epidemiology and Biostatistics, University of California , San Francisco, California , USA

Abstract

Abstract Among 14 049 people with human immunodeficiency virus in care in 2019–2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolutegravir and bictegravir) and tenofovir alafenamide, especially in antiretroviral-naive individuals initiating ART.

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3